203 related articles for article (PubMed ID: 8564847)
21. Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression.
Kamei T; Inui M; Nakamura S; Okumura K; Goto A; Tagawa T
Melanoma Res; 2003 Apr; 13(2):153-9. PubMed ID: 12690298
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry.
Kasahara I; Saitoh K; Nakamura K
J Med Dent Sci; 2000 Sep; 47(3):167-75. PubMed ID: 12160229
[TBL] [Abstract][Full Text] [Related]
23. Fas system and apoptosis in viral hepatitis.
Hayashi N; Mita E
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S223-6. PubMed ID: 9407341
[TBL] [Abstract][Full Text] [Related]
24. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
25. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
[TBL] [Abstract][Full Text] [Related]
26. Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice.
Nagaki M; Sugiyama A; Osawa Y; Naiki T; Nakashima S; Nozawa Y; Moriwaki H
J Hepatol; 1999 Dec; 31(6):997-1005. PubMed ID: 10604572
[TBL] [Abstract][Full Text] [Related]
27. Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice.
Tsubata T; Murakami M; Honjo T
Curr Biol; 1994 Jan; 4(1):8-17. PubMed ID: 7922322
[TBL] [Abstract][Full Text] [Related]
28. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
29. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
30. Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis.
Chang B; Nishikawa M; Sato E; Inoue M
Arch Biochem Biophys; 2003 Mar; 411(1):63-72. PubMed ID: 12590924
[TBL] [Abstract][Full Text] [Related]
31. Liver repopulation by Bcl-x(L) transgenic hepatocytes.
Mitchell C; Mallet VO; Guidotti JE; Goulenok C; Kahn A; Gilgenkrantz H
Am J Pathol; 2002 Jan; 160(1):31-5. PubMed ID: 11786395
[TBL] [Abstract][Full Text] [Related]
32. Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-X(L) expression.
Otani Y; Tsutsumi K; Kuwahara D; Oyake D; Ohta T; Nishikawa H; Koizuka I
Auris Nasus Larynx; 2003 Feb; 30 Suppl():S79-84. PubMed ID: 12543166
[TBL] [Abstract][Full Text] [Related]
33. HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice.
Honda A; Hatano M; Kohara M; Arai Y; Hartatik T; Moriyama T; Imawari M; Koike K; Yokosuka O; Shimotohno K; Tokuhisa T
J Hepatol; 2000 Sep; 33(3):440-7. PubMed ID: 11020000
[TBL] [Abstract][Full Text] [Related]
34. Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta.
Mukherjee D; Kaestner KH; Kovalovich KK; Greenbaum LE
Hepatology; 2001 May; 33(5):1166-72. PubMed ID: 11343245
[TBL] [Abstract][Full Text] [Related]
35. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
36. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
Lamboley C; Bringuier AF; Feldmann G
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
Memon SA; Moreno MB; Petrak D; Zacharchuk CM
J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2 does not inhibit the permeability transition pore in mouse liver mitochondria.
Yang JC; Kahn A; Cortopassi G
Toxicology; 2000 Oct; 151(1-3):65-72. PubMed ID: 11074301
[TBL] [Abstract][Full Text] [Related]
39. Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2a(b)-producing B cells.
Majlessi L; Bordenave G
Int Immunol; 2000 Jul; 12(7):969-76. PubMed ID: 10882408
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity.
Manero F; Ljubic-Thibal V; Moulin M; Goutagny N; Yvin JC; Arrigo AP
Cell Stress Chaperones; 2004; 9(2):150-66. PubMed ID: 15497502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
